News Sentiment

ACHV sentiment intelligence

Achieve Life Sciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 55 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.11 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-4.5% over one week, +10.7% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Canaccord reiterates Achieve Life Sciences stock rating on CRL review

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 77/100 classification
One-week reaction -4.5% Price reacting lower
Trend fit Trend active 10.7% over four weeks
Fair value 46.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 38
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 10
Investing.com 5
GlobeNewswire 5
TradingView 4
Seeking Alpha 2
TradingKey 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 20
Analyst action 4
Regulatory and legal 4
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-55 of 55
GlobeNewswire Direct company coverage

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

Achieve Life Sciences has appointed Jeffrey Farrow and Reid Waldman, MD to its Board of Directors to bolster the company's commercial strategy, clinical, and finance expertise. These appointments come as Achieve prepares for the potential approval and launch of cytisinicline, a t

Tone
Positive 72/100
Event
Regulatory and legal
Published
03 Jun 2026 09:09
Source
GlobeNewswire
Stock Titan Direct company coverage

ACHIEVE Life Sciences (ACHV) director reports no beneficial ownership on Form 3

ACHIEVE Life Sciences, Inc. director Reid Alexander Waldman filed an initial Form 3, indicating no beneficial ownership of the company's securities with 0 shares held directly. This filing establishes his baseline holdings as he becomes a reporting insider, offering transparency

Tone
Neutral 50/100
Event
Market update
Published
02 Jun 2026 20:18
Source
Stock Titan